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Abstract
Purpose: The need for longitudinal studies on prenatal substance exposure (PSE) extending into
adulthood is widely recognised. In particular, studies on the dual effect of exposure to substances
and adverse childhood experiences are needed. This register-based matched cohort study
investigates the effect of this dual exposure on the health and development of youth with PSE. The
follow-up is from birth to young adulthood. Participants: The exposed youth were born in 1992–
2001 to mothers with a significant substance misuse problem during pregnancy. The mothers were
identified in primary care maternity clinics in the Helsinki metropolitan area and referred for
intensified pregnancy follow-up in a tertiary care setting (HAL-clinics). Data from hospital medical
records were collected for the mothers during the pregnancy follow-up and linked with register
data from multiple national health and social welfare registers obtained for each mother–child dyad
from birth until the end of 2015–2018. Similar register data were gathered for three matched
mother–child dyads without any evidence of the mother’s substance misuse in national health and
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social welfare registers. The study consists of 615 exposed and 1787 unexposed youth aged
15–24 years. Findings to date: A majority of the exposed youth (64%) had been in out-of-home
care at least once compared with 8% among the unexposed. Outpatient and inpatient hospital care
due to mental or behavioural disorders were two to three times more common among the
exposed than among the unexposed. The exposed had less often completed secondary school
education and had more often needed social assistance. Future plans: The data comprise a wide
range of information on infant health, youth’s mental and somatic health and development, out-of-
home care history, and mother’s life situation at the delivery and later health. Risk and protective
factors for different long-term developmental outcomes in adolescence or in young adulthood will
be studied.
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Introduction
Alcohol crosses the placenta easily and dam-
ages the development of the brain and other
organs of the foetus (Popova, Lange, Probst,
Gmel, & Rehm, 2017). Detrimental effects of
prenatal alcohol exposure (PAE) manifest
as cognitive dysfunction (Riley, Infante, &
Warren, 2011), congenital anomalies and mor-
bidity (Popova et al., 2016) and mental and
behavioural disorders later in life (Khoury,
Jamieson, & Milligan, 2018; Weyrauch,
Schwartz, Hart, Klug, & Burd, 2017). Other
substances also cross the placenta rapidly and
can alter brain neurotransmitters and brain bio-
chemistry (Behnke, Smith, & Committee on
Substance Abuse, 2013) but less is known about
the long-term effects of exposure to substances
other than alcohol (Irner, 2012). However, prob-
lems in cognitive development (Bunikowski
et al., 1998; Eriksson, Jonsson, Steneroth, &
Zetterstro¨m, 2000), attention, language devel-
opment and behaviour (Behnke et al., 2013;
Irner, 2012) have also been found in adoles-
cents with prenatal exposure to illegal drugs.
No excess risk for congenital anomalies has
been reported (Behnke et al., 2013; Minnes,
Lang, & Singer, 2011).
Because women with substance misuse
problems typically are polydrug users (Pajulo,
Savonlahti, Sourander, Helenius, & Piha, 2001;
Sarkola, Kahila, Gissler, & Halmesma¨ki, 2007)
it is difficult to differentiate the effect of an
individual drug on the development of the
exposed child. Moreover, childhood maltreat-
ment can cause similar structural damage to the
brain as PAE, which manifests as cognitive and
behavioural dysfunction (Glaser, 2000; Hart &
Rubia, 2012). However, the interaction between
PAE and adverse experiences has not been well
studied (Koponen, 2006; Koponen, Kalland, &
Autti-Ra¨mo¨, 2009; Koponen, Kalland, Autti-
Ra¨mo¨, Laamanen, & Suominen, 2013; Price,
Cook, Norgate, & Mukherjee, 2017). Studies
on prenatal drugs exposure (PDE) have more
systematically investigated the effects of envi-
ronmental risk factors. These studies share the
view that adverse childhood experiences
(ACEs) have a strong negative effect on the
exposed children’s and adolescents’ cognitive
and emotional development (Ackerman,
Riggins, & Black, 2010; Buckingham-Howes,
Berger, Scaletti, & Black, 2013; Lambert &
Bauer, 2012; Minnes et al., 2011). Still, more
longitudinal studies extending into adolescence
and adulthood are needed (Irner, 2012). Previ-
ous studies on PAE and PDE have also been
criticised for moderate sample sizes and insuf-
ficient numbers of variables describing adver-
sity (Irner, 2012; Minnes et al., 2011; Price
et al., 2017). In the ADEF Helsinki research
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project (Alcohol/Drugs Exposure during Foetal
life), we are able to avoid many of these
problems.
ADEF Helsinki is a longitudinal register-
based matched (exposed/unexposed youth)
cohort study. The study investigates (1) the
overall developmental outcomes (congenital
anomalies, somatic health, mental and beha-
vioural disorders, attention deficit hyperactivity
disorder (ADHD) and learning problems, med-
ication, education, need for income support,
problems with the law, rehabilitation, abortions,
parity, pregnancies, and health of the next gen-
eration) of adolescents and young adults with
prenatal substance exposure (PSE), and (2) the
effect of the dual exposure to PSE and ACES on
the developmental outcomes of these young
people. The variables measuring ACEs are:
mother’s sociodemographic characteristics
(age, marital status, and socioeconomic status),
mother’s health and well-being (mental health
problems, continued substance misuse, criminal
record, income support, and death), and youth’s
out-of-home care history (age at the first place-
ment, number of placements, proportion of time
living in out-of-home care, and family/residen-
tial care). Developmental outcomes of exposed
and unexposed youth are compared, as well as
the effects of ACEs in both groups.
We hypothesise that developmental prob-
lems are more common among the exposed
than among the unexposed, and that ACEs
increase all developmental problems in both
groups and decrease the differences between
them. In the present cohort profile, we describe
the data and report some first results in the long-
term developmental outcomes of exposed and
unexposed adolescents and young adults.
Cohort description
This is a longitudinal population- and register-
based cohort study comparing adolescents and
young adults with and without PSE. Mothers of
the exposed youth were first identified by pub-
lic health nurses in the maternity clinics of pri-
mary healthcare centres in the Helsinki
metropolitan area. The nurses were educated
and advised to refer pregnant women with a
significant substance misuse problems (The
Alcohol Use Disorders Identification Test  8
or illegal drug misuse or nonmedical use of
central nervous system medication or opioid
maintenance treatment) to special antenatal
HAL-clinics (illicit drugs, alcohol, medicines)
at HUS (The Hospital District of Helsinki and
Uusimaa) for counselling and intensified
follow-up. Pregnancies were followed up in a
multidisciplinary service setting consisting of
outpatient antenatal treatment and counselling
provided by an obstetrician, a nurse, a mid-
wife, a psychiatric nurse, and a social worker
experienced in addiction treatment teamwork.
Follow-up visits were individualised from
daily visits to visits every four weeks, and
women were offered intensified support and
easy access to addiction treatment and/or
psychiatric care (Kahila, Gissler, Sarkola,
Autti-Ra¨mo¨, & Halmesma¨ki, 2010; Kahila,
Saisto, Kivitie-Kallio, Haukkamaa, & Halmes-
ma¨ki, 2007).
In 1992–2001, 526 pregnant women with
identified substance misuse problem (substance
misusing mothers), were followed at the HAL-
clinics giving birth to 640 infants (0.4% of all
children born in the region). Two of the infants
could not be linked due to an incomplete mater-
nal identification number. Thus, the original
exposed cohort in the first follow-up study con-
sisted of 638 exposed children and 524 sub-
stance misusing mothers (Figure 1).
The matched control cohort was obtained
from the national Medical Birth Register and
consisted of 1914 unexposed children born in
1992–2001 to women with no evidence of alco-
hol and/or substance misuse (n ¼ 1792) in any
of the national health and social welfare regis-
ters. Three mother–child unexposed dyads were
matched with each exposed mother–child dyad
for maternal age, parity, number of foetuses, the
month of delivery, and delivery hospital of the
index child. Because matching was carried out
for maternal characteristics, children were not
matched by sex. The proportion of boys among
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the born children in Finland is 51.1% (Statistics
Finland). In our data, the proportion of boys
among exposed is 49.3%, and among unex-
posed 51.7% (Figure 1).
Hospital medical records were reviewed for
substance misusing mothers during the antena-
tal and perinatal follow-up as well as for new-
borns until discharge from the maternity
hospital. Register data were obtained from the
multiple mandatory national health and social
welfare registers for each exposed and unex-
posed dyad (Table 1). Data linkage of all
registers was made by using the unique identi-
fication number assigned to each Finnish
citizen at birth or immigration (Kahila et al.,
2007). Mothers’ and children’s identification
numbers were concealed and replaced with
study numbers after the data linkages.
Follow-ups
The first follow-up for exposed dyads (N ¼
638) and matched unexposed dyads (N ¼
1914) extending from birth until the end of
2007 (or emigration or death) has been com-
pleted (median follow-up ¼ 9 years, range
5–15 years). In the second (ongoing) follow-
up, data collection extended from birth until the
1991–2001
526 pregnant women with substance misuse prob-
lems were identified by primary healthcare nurses 
in the maternity clinics of healthcare centres of 
Helsinki metropolitan area and referred to the HAL-
clinics for intensified follow-up and multidiscipli-
nary counselling during pregnancy. 
1992–2001 
- 640 children were born to these 526 women (0.4% 
of all 172600 live-born children in the area). 
EXPOSED CHILDREN
The first follow-up: birth →2007 
- Mothers, n = 524 (missing ID, n = 2)
- Children, n = 638 (missing ID, n = 2)
- Died in infancy, n = 7
- Alive, n = 631
- DATA: Hospital medical records collected during 
the pregnancy follow-up+register data (0–15 years)
UNEXPOSED CHILDREN
The first follow-up: birth →2007 
- Mothers, n = 1792
- Children, n = 1914
- Died in infancy, n = 8
- Alive, n = 1906
- DATA: Register data (0–15 years)
EXPOSED CHILDREN
The second follow-up: birth →2016
Follow-up years until 2016, mean 18.8, SD 3.6
- Children, n = 615 (missing = 16, 2.5%)
- Female 312 (50.7%)
- Died during the follow-up, n = 8
- DATA: Hospital medical records collected during 
the pregnancy+register data (0–24 years)
UNEXPOSED CHILDREN
The second follow-up: birth→2016
Follow-up years until 2016, mean 18.6, SD 3.9
- Children, n = 1787 (missing = 119, 6.2%)
- Female 864 (48.3%)
- Died during the follow-up, n = 19
- DATA: Register data (0–24 years)
Figure 1. The data collection process.
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HAL-clinics ¼ intensified pregnancy follow-up in a tertiary care setting; THL ¼ Finnish National Institute for Health and
Welfare; FASD ¼ foetal alcohol spectrum disorders; ICD ¼ International Statistical Classification of Diseases and Related
Health Problems by World Health Organization, WHO; VRK ¼ Central Population Register; ETK ¼ Finnish Centre for
Pensions; KELA ¼ Social Insurance Institution; ATC ¼ Anatomical Therapeutic Chemical Classification System by WHO;
LRC ¼ Legal Register Centre.
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end of 2015–2018 depending on the availability
of register data (Table 1). Most of the register
data were available until the end of 2015 or
2016. In 2016 the median age in the youth
cohort was 18 years (range 15–24 years).
Youth’s criminal records were received until
the end of 2017, and mothers’ criminal records
until the end of 2018.
The second follow-up consists of 615 exposed
and 1787 unexposed dyads (Figure 1). Seven of
the 638 exposed and eight of the 1914 unexposed
children were stillborn. Of the 631 exposed and
1906 unexposed children born alive, one exposed
and 74 unexposed had missing/secured ID infor-
mation, which resulted in 630 exposed and 1832
unexposed children. Due to the inclusion criteria
of being born between 1992 and 2001, in total 15
exposed and 42 unexposed children were
excluded due to incorrect birth year (either 1991
or 2002–2003). Further, one unexposed with
FAE-diagnosis (foetal alcohol effects) and two
others with NAS-diagnosis (neonatal abstinence
syndrome) were excluded. The final study popu-
lation consists of 615 exposed and 1787 unex-
posed youths born between 1992 and 2001. A
total of 15 (2.4%) exposed and 27 (1.4%) unex-
posed children had died either in infancy or later.
Measures
In the ongoing second follow-up, we use the hos-
pital medical records from the HAL-clinics and
register data thatwere collected from the national
health and social welfare registers for the first
follow-up, andwe have extended the register data
collection from 2007 to 2015–2018. Additional
register data (Criminal Records, Register of Pri-
mary Healthcare Visits, and Register of Induced
Abortions) havebeen added to the database at this
stage to complete the long-term evaluation.
Maternal characteristics, prenatal
substance exposure, and infant health
at birth
Data on prenatal substance exposure (alcohol,
illegal/legal drugs) were received from the
medical follow-up records of HAL-clinics
(based on observations of healthcare personnel,
mothers’ own reporting and voluntary urine
toxicology screenings if consent was given).
Diagnoses on FASD (foetal alcohol spectrum
disorders) and congenital anomalies (ICD-9
diagnoses) International Statistical Classifica-
tion of Diseases and Related Health Problems
were received from the Register on Congenital
Anomalies provided by the Finnish Institute for
Health and Welfare (THL). The Medical Birth
Register (THL) was the data source for the
health of the neonates (exposure to smoking,
gestational age, birth weight and height, Apgar
scores, need of intensive care and birth defects)
and for mother’s life situation at the time of
delivery (age, marital status, cohabitation,
socioeconomic status, pregnancy complica-
tions, and numbers of previous births, pregnan-
cies, miscarriages, and abortions) (Table 1).
Follow-up data on youth
Youth follow-up data include education, socioe-
conomic status (Statistics Finland), marital status
and live-born children (Population Register Cen-
tre), earning periods and disability pensions (Fin-
nish Centre for Pensions, ETK; Social Insurance
Institution, KELA), criminal records (Legal Reg-
ister Centre, LRC), social assistance (THL), and
special care allowances (KELA).Health data con-
sist of primary diagnoses (ICD-9, ICD-10) from
inpatient and/or outpatient hospital care (THL),
primary diagnoses (ICD-10) from primary care
health centres, induced abortions, deliveries, and
congenital anomalies among the offspring (THL),
reimbursed prescribed medicines (KELA), dates
and causes of deaths (Statistics Finland), and reha-
bilitation (KELA). Data on out-of-home care
including age at first placement, number of place-
ments, years and type (foster home, institution,
kinship care) were provided by THL.
Follow-up data on mothers
Maternal follow-up data, obtained from the
same registers as data on youth, included
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primary diagnoses (ICD-9, ICD-10) based on
inpatient and/or outpatient visits in hospitals
(THL). When the mother’s substance misuse
was defined, secondary diagnoses and external
causes were also used. Additional follow-up
data consisted of dates and causes of deaths
(Statistics Finland), criminal records (LRC),
social assistance (THL), rehabilitation (KELA),
special care allowances (KELA), and institu-
tional care in social welfare institutions,
including care for mental health disorders and
care for alcohol- and drug-related problems
(THL). Table 1 shows the summary of the reg-
isters and data.
Results
Findings and publications of the first
follow-up
Results of the first follow-up from birth until the
end of 2007 have been reported in articles by
Kahila et al. (2007, 2010),Sarkola,Gissler,Kahila,
Autti-Ra¨mo¨, and Halmesma¨ki (2011, 2012) and
Sarkola et al. (2007). The results showed that the
mean age of the substance misusing and non-
misusing mothers was 27 years (SD ¼ 6 years),
and about half the mothers in both groups were
expecting their first child. Substance misusing
mothers displayed significant long-term morbid-
ity,mortality and loss of productivity after delivery
(Kahila et al., 2007). Seven (1.1%) of the exposed
children and 8 (0.4%) of the unexposed children
were born dead or died during infancy. During
their first decade of life, the exposed children fre-
quently used healthcare services for mental and
behavioural disorders, especially those who were
placed in out-of-home care (Sarkola et al., 2011).
Postnatal maternal substance misuse-related mor-
bidity was associated with significant early child
morbidity, use ofmedication and timing of out-of-
home care (Sarkola et al., 2012).
First results of the second follow-up
Of the 615 exposed adolescents and adults in
the ongoing second follow-up, 175 (28.5%)
were exposed to alcohol only, 63 (10.2%) to
illegal drugs only, 63 (10.2%) to both alcohol
and illegal drugs, and 314 (51.1%) had an
unspecified substance exposure (multiple sub-
stance use, not possible to classify to the men-
tioned ‘pure’ categories) history during
pregnancy. These figures were based on hospi-
tal medical records. NAS was reported in 50
(8.1%), and FASD (diagnosed FAS (foetal
alcohol syndrome), FAE/suspected FAS, and
ARBD (alcohol-related birth defect)) later diag-
nosed in 46 (7.5%) among the exposed.
Ongoing maternal smoking during pregnancy
was prevalent (75.3%) among the exposed. The
corresponding proportion of daily maternal
smoking among the unexposed was 18.9%. The
exposed children had lower birth weight and
were more often followed in neonatal intensive
care units. Sixteen per cent of them had at least
one congenital anomaly (unexposed 9.2%), and
2.1% were intellectually disabled (unexposed
0.8%) (Table 2).
Compared with non-misusing mothers, sub-
stance misusing mothers had lower socioeco-
nomic status and were less often married at
the time of the child’s birth, and many died
during the follow-up. Of the exposed youth,
11.5% had lost their mother compared with
0.7% among unexposed (Table 2).
Approaching adulthood, exposed adolescents
and adults faced more difficulties than their
unexposed age-mates. Exposed youths had less
often completed secondary school education,
more often received social assistance and had
more outpatient and inpatient hospital visits due
to any diagnoses and due to mental and beha-
vioural disorder diagnoses, including ADHD and
intellectual disability. A majority of exposed
youths (63.9%) had been placed outside the bio-
logical parent’s home at least once during the
follow-up (unexposed 8.2%), and 5.2% had at
least one criminal record (unexposed 0.9%).
Discussion
The data of the present study consist of a
unique combination of medical records and
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register data with large sample size, a large
number of variables describing adverse child-
hood experiences and other background fac-
tors extending from birth to young adulthood.
We are able to provide a broad and reliable
overview of the nature and extent of the
potential problems that adolescents and
young adults with a history of prenatal sub-
stance exposure face in their life and to iden-
tify factors associated with these problems.
This research will be of interest both inter-
nationally and nationally.
The reporting to the national health and social
welfare registers used in this study is obligatory,
and their good coverage and quality have been
ascertained (Aro, Koskinen, & Keskima¨ki, 1990;
Gissler & Haukka, 2004). Medical data are
based on primary diagnoses and statements
made by medical professionals and registered
in national databases. The Finnish Hospital Dis-
charge Register has been found to be a valid
and reliable tool for epidemiological research
(Sund, 2012). A register-based study design
avoids problems related to the participation,
Table 2. Follow-up data of the 1992–2001 cohort (second follow-up, exposed n ¼ 615, unexposed
n ¼ 1787).
Exposed n (%) Unexposed n (%) p-value
Infant health
Daily maternal smoking during pregnancy 463 (75.3) 337 (18.9) < 0.001
Birth weight < 2500 g 77 (12.5) 120 (6.7) < 0.001
Apgar score at one minute 0–6 25 (4.1) 60 (3.4) 0.409
Neonatal intensive care during the first 7 days of life 127 (20.7) 176 (9.8) < 0.001
Any congenital anomaly 96 (15.6) 164 (9.2) < 0.001
Major congenital anomaly 68 (11.1) 80 (4.5) < 0.001
Mother’s life situation at delivery
Mother’s age less than 20 years 71 (11.5) 195 (10.9) 0.967
Married 125 (20.5) 1059 (60.1) < 0.001
Higher socioeconomic status (mother self-employed
or upper- or lower-level employee at the time of
the child’s birth)
190 (34.3) 966 (57.3) < 0.001
Life situation in adolescence or young adulthood
Married 10 (1.6) 28 (1.6) 0.909
Completed secondary school education 110 (17.9) 419 (23.4) 0.004
Social assistance starting at age 18 years or later 214 (34.8) 248 (13.9) < 0.001
At least one episode of out-of-home care 393 (63.9) 147 (8.2) < 0.001
Criminal record 32 (5.2) 16 (0.9) < 0.001
Maternal death during the follow-up 71 (11.5) 13 (0.7) < 0.001
Health in adolescence or young adulthood
At least one outpatient visit, all diagnoses 592 (96.3) 1594 (89.2) < 0.001
At least one inpatient visit, all diagnoses 420 (68.3) 917 (51.3) < 0.001
Child death during the follow-up 8 (1.3) 19 (1.1) 0.630
Mental and behavioural disorders in adolescence and young adulthood
Outpatient visit with F-diagnosis 333 (54.1) 466 (26.1) < 0.001
Inpatient visit with F-diagnosis 129 (21.0) 121 (6.8) < 0.001
Outpatient visit due to ADHD ICD-10: F90 76 (12.4) 64 (3.6) < 0.001
Inpatient visit due to ADHD ICD-10: F90 16 (2.6) 6 (0.3) < 0.001
Intellectual disability ICD-10: F70-79 13 (2.1) 15 (0.8) < 0.001
F-diagnosis ¼ Mental and behavioral disorders; ADHD ¼ attention deficit hyperactivity disorder; ICD ¼ International
Statistical Classification of Diseases and Related Health Problems by WHO.
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response, and recall bias. No participants are
contacted and personal identification is impossi-
ble after the data linkages. All data are confiden-
tial, and no harm is caused to the participants.
In Finland, 99.7% of all pregnant women
attend antenatal services provided by maternity
clinics at healthcare centres (Kahila et al.,
2010), which made it possible to identify preg-
nant women with a substance misuse problem.
Prenatal substance exposure was confirmed and
was considered significant during the preg-
nancy follow-up. Identification of mothers’
substance use was based on mothers’ own
reporting, voluntary urine toxicology screen-
ings, and observations and other information
received by healthcare personnel in the
maternity clinics and during the pregnancy
follow-up. The substance-exposed children in
the present study represent 0.4% of all children
born in the Helsinki metropolitan area in 1992–
2001 (Kahila et al., 2007). International
(Popova et al., 2017) and national (Pajulo
et al., 2001) prevalence estimations of the sub-
stance misuse problem during pregnancy are
much higher, which indicates that only the most
severe cases were identified and included in the
study. Only a few exposed children were diag-
nosed, which shows that FASD is an underdiag-
nosed disorder.
The study has also limitations. As in all
studies on prenatal substance exposure
(Behnke et al., 2013), detailed information
on the type, timing and amount of exposure
is limited, and all pregnant women with sub-
stance misuse problems in the catchment
area may not have been identified. There-
fore, the data are likely to be biased to those
with the heaviest substance use, and they do
not reveal the effects of slight and/or occa-
sional substance use. Another limitation is
that we cannot be sure that women in the
non-misuse group had not used any sub-
stances. However, all registers were carefully
checked in order to rule out this possibility,
and if any sign was noticed, these women
and their children were removed from the
data.
The proportion of missing cases lost from
the first follow-up to the second was somewhat
larger among the unexposed children. It is
unlikely that this has any effect on the results
as three unexposed children were matched with
each exposed child.
Child abuse and neglect have a strong nega-
tive effect on child development (Hart, &
Rubia, 2012) but this information could not be
obtained from the registers. However, a major-
ity of exposed adolescents and young adults had
been placed in out-of-home care at least once
which indicates that many of them may have
faced these adversities as previously reported
by Kalland and Sinkkonen (2001). Finally, one
limitation of register studies is that it is impos-
sible to collect additional primary data if
needed.
The first results of this second follow-up of
the data showed that a very high percentage of
the exposed youth had been in out-of-home
care, their mental health problems continued
to youth age, and their educational level was
lower compared with the unexposed. The
results are in line with earlier studies on indi-
viduals with PSE (Irner, 2012; Popova et al.,
2016; Streissguth, Barr, Kogan, & Bookstein,
1996; Streissguth et al., 2004). In upcoming
research articles, we will focus on analysing
interactions between PAE, PDE, ACEs, and
developmental outcomes among youth with and
without PSE.
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